Metabolism
Metabolism encompasses the sum of biochemical processes that sustain life, including catabolic pathways like Yeasts and Fermentation and anabolic or regulatory responses to substrates such as Xylitol. It dictates energy production (ATP), gas generation for leavening, and flavor compound synthesis in food systems, while also governing species-specific toxicological responses.
Yeast Fermentation
Yeast fermentation is an anaerobic metabolic pathway wherein Saccharomyces cerevisiae metabolizes carbohydrates (primarily glucose and fructose) into carbon dioxide and ethanol, generating ATP for cellular survival. In culinary applications, it functions as a biological leavening agent and flavor precursor through the accumulation of organic acids, esters, and alcohols.
Mechanisms
- Glycolysis: Enzymatic degradation of sugars to pyruvate; kinetics modulated by temperature, sugar concentration, and osmotic stress.
- Gas Expansion: CO2 entrapment within gluten matrices drives volume increase; retention relies on dough elasticity, hydration, and surface tension.
- Flavor Biochemistry: Secondary metabolites yield complexity; extended fermentation elevates acetic-acid and lactic-acid ratios, enhancing sourness and crumb structure development.
Kinetic Factors
- Temperature: Optimal activity 70–80°F (21–27°C); cold retardation inhibits metabolic rate, preserving gas retention and extending fermentation window.
- Osmotic Regulation: High sugar/salt concentrations reduce water activity, stressing yeast; salt simultaneously regulates enzyme activity.
Xylitol Metabolism and Toxicity
Integrate insights from Xylitol: Human Health Benefits and Canine Toxicity:
- Source & Properties: Naturally occurring sugar alcohol found in plants and mushrooms; sweetness comparable to sucrose but with ~40% fewer calories.
- Human Metabolism: Slowly absorbed in the small intestine and partially metabolized without requiring insulin, resulting in a low glycemic index and minimal impact on blood sugar levels.
- Canine Toxicity: Highly toxic to dogs due to rapid absorption and subsequent stimulation of insulin release, causing hypoglycemia; potential for acute liver failure at higher doses.